Applied DNA Sciences' (APDN) CEO James Hayward on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Dec 16, 2:12PM CST
APDN: 2.94 (+0.01)
Applied DNA Sciences net loss improves in FY14
Seeking Alpha - at Seeking Alpha - Tue Dec 16, 6:24AM CST
APDN: 2.94 (+0.01)
Applied DNA Sciences EPS of -$0.97
Seeking Alpha - at Seeking Alpha - Tue Dec 16, 6:04AM CST
APDN: 2.94 (+0.01)
Applied DNA Sciences Reports Fiscal Year End 2014 Results
Marketwired - Tue Dec 16, 6:01AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced its year-end results of fiscal 2014.
APDN: 2.94 (+0.01)
Applied DNA Sciences' Anti-Theft System Recommended by Sweden Police, Insurance Officials
Marketwired - Tue Dec 16, 4:30AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, highlighted today remarks by a high-level Stockholm police official, and an insurance spokesman urging car owners to use the APDN anti-theft product smartDNA® to protect their cars and car parts from criminals. The two experts in car theft prevention were cited in Sweden's largest-circulation newspaper, Aftonbladet.
APDN: 2.94 (+0.01)
Applied DNA Sciences Elects Joseph Ceccoli to Board of Directors
Marketwired - Tue Dec 09, 7:30AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, has elected Joseph Ceccoli, Founder, President and CEO of Biocogent, LLC, as a member of the company's Board of Directors. Biocogent is a bioscience company, focused on the invention, development and commercialization of skin-active molecules and treatment, and consumer products sold globally in 15 countries.
APDN: 2.94 (+0.01)
Applied DNA Sciences Schedules Fiscal Fourth Quarter and Year-End 2014 Webcast for December 16, 2014 at 9:00 AM EST
Marketwired - Mon Dec 08, 6:30AM CST
Applied DNA Sciences (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, will host a conference call on Tuesday December 16, 2014 at 9:00 AM EST to discuss its fiscal fourth quarter and year -end results. The Annual Report Form 10K will be filed with the SEC by the end of the day on Monday December 15, 2014, and the press release will be issued prior to the call.
APDN: 2.94 (+0.01)
Applied DNA Sciences enters into security agreement with fourth federal agency
M2 - Fri Dec 05, 4:26AM CST
DNA anti-counterfeiting company Applied DNA Sciences (APDN) (NasdaqCM:APDN) reported on Thursday the execution of an agreement for use of its SigNature DNA anti-counterfeiting technology, valued at upwards of USD250,000, with a fourth government agency.
APDN: 2.94 (+0.01)
Applied DNA Sciences signs up fourth government agency
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 8:19AM CST
APDN: 2.94 (+0.01)
Applied DNA Sciences to Participate in Two Investor Conferences on Thursday, December 11
Marketwired - Thu Dec 04, 7:32AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, will participate in two investor conferences on Thursday, December 11. Company management will discuss the Company's botanical-DNA based security and authentication solutions and services.
APDN: 2.94 (+0.01)
Applied DNA Sciences Signs With Fourth Federal Agency
Marketwired - Thu Dec 04, 4:30AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has signed an agreement for use of its SigNature® DNA anti-counterfeiting technology with a government agency. The initial agreement is valued at upwards of $250,000.
APDN: 2.94 (+0.01)
Applied DNA Sciences concludes USD9.1m offering of common stock and warrants
M2 - Fri Nov 21, 6:05AM CST
Anti-counterfeiting company Applied DNA Sciences (NasdaqCM:APDN) (Twitter:APDN) disclosed on Thursday that it has the closed its public offering of 2,800,000 common stock and warrants to purchase up to an aggregate of 2,800,000 common shares at an offering price of USD3.24 per share and USD0.01 per warrant.
APDN: 2.94 (+0.01)
Applied DNA Sciences Inc. Announces Closing of $9.1 Million Underwritten Offering
Marketwired - Thu Nov 20, 3:30PM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, announced the closing of an underwritten public offering of 2,800,000 shares of common stock, and warrants to purchase up to an aggregate of 2,800,000 shares of common stock, at an offering price of $3.24 per share and $0.01 per warrant. The warrants have a per share exercise price of $3.50, are exercisable immediately, and expire five years from the date of issuance. The gross proceeds to Applied DNA Sciences from this offering are approximately $9.1 million before deducting the underwriting discount and other offering expenses. The Company has granted the underwriters a 45-day option to purchase up to an aggregate of 420,000 additional shares of common stock and/or up to 420,000 additional warrants to cover over-allotments, if any.
APDN: 2.94 (+0.01)
Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 Million Underwritten Offering
Marketwired - Tue Nov 18, 11:19PM CST
Applied DNA Sciences, Inc., (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, announces approval to list its common stock and warrants on the NASDAQ Stock Market, LLC effective November 17, 2014, and will trade under the symbols APDN and APDNW, respectively.
APDN: 2.94 (+0.01)
Applied DNA Sciences Implements Reverse Stock Split, Effective Wednesday, October 29 Temporary trading symbol: APDND
GlobeNewswire - Wed Oct 29, 2:26PM CDT
via PRWEB - Applied DNA Sciences, Inc. (OTCQB: APDND), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced that its 1-for-60 reverse split of its common stock became effective at the beginning of trading today, Wednesday, October 29, 2014.
APDN: 2.94 (+0.01)
Applied DNA Sciences Announces Reverse Stock Split
GlobeNewswire - Tue Oct 28, 4:04PM CDT
via PRWEB - Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today a 1-for-60 reverse split of its common stock that will be effective at 12:01AM on Wednesday, October 29, 2014 and in effect at the opening of trading on Wednesday, October 29, 2014. The reverse stock split was approved by the company's shareholders at the 2014 Annual Shareholder's Meeting, held August 28, 2014, at the specific ratio determined by the Board of Directors.
APDN: 2.94 (+0.01)
Applied DNA Sciences to Provide "Fiber Forward" Supply Chain Protection for Extra Long Staple Pima Cotton
GlobeNewswire - Tue Oct 28, 7:34AM CDT
via PRWEB - Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today a commercial agreement with a textile manufacturer to purchase a SigNature T(R) DNA mark, in order to protect and authenticate Extra Long Staple Pima cotton starting October 27, 2014. This agreement will enable the textile manufacturer and its large retail partners to assure quality and preserve the integrity of the textile supply chain, starting from the grower to the consumer.
APDN: 2.94 (+0.01)